MEKTOVI Pierre Fabre Australia Pty Ltd

Mektovi (binimetinib) and encorafenib are used together to treat adult patients with melanoma that cannot be removed by surgery or has spread to other parts of the body. Mektovi is for patients with melanoma that carry particular genetic changes in the BRAF gene called “V600E” or “V600K”. Mektovi Mektovi (binimetinib) and encorafenib are also used together to treat adult patients with advanced non-small cell lung cancer that has the BRAF V600E genetic change.